Target Audience:
The activity is designed for all health care professionals involved in diabetes research or the delivery of diabetes care and services. This includes physicians, doctors of osteopathy, international physicians, physician assistants, nurses, dietitians, certified diabetes educators and other health care professionals.
Learning Objectives:
• Explain the scientific rationale for the use of dipeptidyl peptidase-4 inhibitors as antihyperglycemic agents.
• List the clinical implications of blocking the activity of dipeptidyl peptidase-4 as a novel treatment of type 2 diabetes.
• Discuss the properties of the different dipeptidyl peptidase-4 inhibitors in clinical development.
Accreditation Statements
Physicians: The American Diabetes Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Diabetes Association designates this education activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Doctors of Osteopathy: Category 2 credit will be awarded for formal educational programs that are ACCME-accredited or AAFP-approved.
International Physicians: The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 credit™.
Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 CME credit for the organizations accredited by ACCME. ADA is an accredited provider through the ACCME.
Nurses: The American Diabetes Association is approved as a provider of continuing education in nursing by the Virginia Nurses Association (VNA) which is accredited as an approver of continuing education in nursing by the American Nurses’ Credentialing Center’s Commission on Accreditation. The American Diabetes Association is located at 1701 North Beauregard Street, Alexandria, VA 22311. VNA Provider Number: 07-03-02. This educational activity is approved by the Virginia Nurses Association (VNA) which is accredited by the American Nurses Credentialing Center’s Commission on Accreditation as an approver of Continuing Education in Nursing for a maximum of 0.5 VNA Contact Hours. The VNA is located at 7113 Three Chopt Road, Suite 204, Richmond, VA 23226.
California Board of Registered Nursing: The American Diabetes Association is also a provider approved by the California Board of Registered Nursing, Provider No. CEP-12196. This activity is approved for 0.5 contact hours.
 |
Dietitians: The American Diabetes Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 0.5 continuing professional education units (CPEUs) for completion of this program/material.
|
Certified Diabetes Educators: To satisfy the requirement for renewal of certification by continuing education for the National Certification Board for Diabetes Educators (NCBDE), continuing education activities must be diabetes related and approved by a provider on the NCBDE List of Approved Providers (www.ncbde.org). NCBDE does not approve continuing education. The American Diabetes Association is on the NCBDE List of Approved Providers.
Content Validation Statements
• All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR
• All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
Planning Committee:
Harold E. Lebovitz, MD, FACE (program chair)
Professor of Medicine
State University of New York Health Science Center
Brooklyn, NY
Satish Garg, MD
Professor, Departments of Pediatrics and Medicine
University of Colorado School of Medicine
Head, Young Adult Diabetes Clinic
Barbara Davis Center for Childhood Diabetes
Aurora, CO
Kabayam M. Venkat Narayan, MD
Professor of Global Health and Medicine
Emory University, Hubert Department of Global Health
Atlanta, GA
Faculty:
Carolyn Deacon, PhD
Senior Lecturer, Department of Biomedical Sciences
University of Copenhagen
Copenhagen, Denmark
DISCLOSURE STATEMENT
As a provider of continuing education through the Accreditation Council for Continuing Medical Education, Virginia Nurses Association, Accreditation Council for Pharmacy Education, the American Psychological Association, and the Commission on Dietetic Registration, it is the Association’s policy to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All participating faculty, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is not to prevent a planner or presenter from being involved in the activity, but rather to provide participants with information on which they can make their own judgments.
Planning Committee:
Harold Lebovitz, MD, FACE
Consultant: Novartis Pharmaceuticals Corporation, sanofi-aventis
Advisory Board: Amylin Pharmaceuticals, Inc.
Speakers Bureau: GlaxoSmithKline
Stockholder: Amylin Pharmaceuticals, Inc., GlaxoSmithKline, sanofi-aventis
Satish Garg, MD
Research Support: NovoNordisk, Eli Lilly, sanofi-aventis, National Institutes of Health, American Diabetes Association, Juvenile Diabetes Research Foundation, Dexom, Medtronic, Johnson and Johnson, Roche.
Speakers Bureau: sanofi-aventis, Johnson and Johnson, Roche
Advisory Panel: NovoNordisk, Eli Lilly, sanofi-aventis, National Institutes of Health, American Diabetes Association, Juvenile Diabetes Research Foundation, Dexom, Medtronic, Johnson and Johnson, Roche
Kabayam M. Venkat Narayan, MD
Disclosed no conflict of interest
Faculty:
Carolyn Deacon, PhD
Employee: Merck & Company., Inc and Novo Nordisk Inc.
Speakers Bureau: Merck & Company, Inc.
Stock/Sherholder: Novo Nordisk Inc.
Other Relationship: Novartis Pharmaceutical Corporation
Commercial Support
This webcast is supported by an unrestricted educational grant from NovoNordisk, Inc.
How to get CE Credit
Successful completion of this CE activity includes the following:
• Registration and completion of the pretest
• View and listen to the lecture and accompanying slide presentation
• Click on the link to apply for CE/CME credit
• Complete the post-test and evaluation
• View/print your CME/CE Certificate from your own printer.
Please note:
• There is no fee for CE credits for this activity.
• Estimated time to view the webcast and complete documentation is 45 minutes.
• Credits are available for this activity from September 1, 2008 through September 1, 2009.
|
